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Background: Campylobacter jejuni, the most leading cause for bacterial gastroenteritis worldwide, shows a high
genetic diversity among its isolates. Recently, we demonstrated the existence of six C. jejuni-groups by combining
MLST with six genetic markers. These groups were further characterized by the detection of cj1321-cj1326, fucP,
cj0178, cj0755/cfrA, ceuE, pldA, cstII, and cstIII in order (I.) to show further associations between these different
genetic markers and MLST CCs. Moreover, different studies were able to associate several of these markers: a
sialylated lipoologosaccharide (cstII/III+), the gamma-glytamyl-transpeptidase (ggt+), and the absence of a certain
allele of the enterochelin-uptake-binding-protein (ceuE11168
- ) with severe campylobacteriosis, bloody diarrhea and
unpleasant outcome. Additionally more than half of human Campylobacter-isolates were assigned to a non-livestock
clade associated with the absence of cj1321-cj1326. These isolates were considered as mere colonizers.
From the combination of marker genes, the ratio of human isolates in a specific group, and clinical data (II.) it
should be demonstrated to which of the previous defined groups these Campylobacter-subpopulations, associated
with higher virulence, correspond.
Results: Besides the marker gene pldA, all new estimated genetic markers show significant differences in their
distribution among the various MLST-based groups. Especially the genes for cj1321-cj1326, fucP, cj0178, cj0755/cfrA
are widely associated with each other and split the study population into two major and seven intermediate
groups substantiating the previous group-definition, whereas cstII and cstIII indicate at least three groups following
an independent distribution pattern.
Conclusions: Based on these data a group of C. jejuni-isolates characterized by the presence of ansB, dmsA, ggt,
and the absence of cj1365c, cj1585c, cj1321-cj1326, fucP, cj0178, cj0755/cfrA, and cstII/III was associated with a higher
prevalence in human campylobacteriosis, bloody diarrhea as well as hospitalization and bears obviously a higher
virulence for humans. In contrast to that better livestock-adapted groups characterized by the ability to utilize
L-fucose and the presence of all of the five identified putative C. jejuni iron-uptake systems as well as cj1321-cj1326,
cj1365c, cj1585c, and cstII and/or cstIII (sialylated lipoologosaccharide) is more prevalent in animal hosts and was
secondary associated with less severe campylobacteriosis.
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The Gram-negative Epsilonproteobacterium Campylobacter
jejuni, which is due to recent epidemiological data the
most leading cause for bacterial gastroenteritis and
Guillain-Barré-syndrome (GBS) worldwide, shows a high
genetic diversity among its isolates [1]. As consequence of
this genetic and phenotypic diversity several C. jejuni sub-
populations could be identified on the basis of the presence
of non-ubiquitous genes [2]. In a previous study we could
identify six C. jejuni groups combining multilocus sequence
typing (MLST) with six genetic markers: ansB, dmsA, ggt,
cj1585c, cj1365c and dimeric tlp7 (Tlp7m + Tlp7c) [2]. Here
we could in particular demonstrate that the genes ansB,
dmsA, ggt occur together in a specific cj1585c- and
cj1365c–negative isolate group [2].
Several studies were able to correlate further genetic
markers with clinical parameters. Thus, the question
was addressed how a sialylated lipoologosaccharide
(LOS) affects the severity of the Campylobacter-trigged
diarrhea [3-5]. It was demonstrated that a sialylated LOS
of the Campylobacter cell wall is associated with an
increased occurrence of bloody diarrhea and a longer
duration of symptoms [3-5].
Champion and coworkers made a further interesting
finding. They demonstrated that 55.7% of C. jejuni iso-
lates from human faeces belong to a non-livestock clade
that misses the flagellin O-glycosylation cluster encoded
by the genes cj1321-cj1326 [6]. Cj1321-cj1326-negative
strains originate mostly from asymptomatic carriers and
the environment. Thus, flagellin O-glycosylation may
play as well a role in cell invasion, and in consequence
for the virulence in humans.
Another study of Feodoroff and coworkers identified a
C. jejuni-subpopulation in which they were able to detect
the gamma-glytamyl-transpeptidase gene (ggt) but not the
fucose permease gene (fucP), the phospholipase A gene
(pldA) and the enterochelin-uptake-binding-protein gene
(ceuE) using pldA- and ceuE-primers derived from the
NCTC 11168 genome sequence (The corresponding genes
are designated in the following as pldA11168 and ceuE11168)
[7]. These isolates could be associated with a higher rate
of hospitalizations and bloody diarrhea [7].
To determine the distribution of these further genetic
markers as well as their association with ansB, dmsA,
ggt, cj1585c, cj1365c and dimeric tlp7 and secondary
their correlation with the clinical data of the above men-
tioned studies, we further characterized the same 266
isolates by screening for the presence of eight additional
genetic markers: the flagellin O-glycosylation locus
cj1321-cj1326 [6], the L-fucose permease gene fucP [8],
the outer membrane siderophore receptor cj0178 [9,10],
the iron uptake protein/ferric receptor cj0755/cfrA
[9,10], the enterochelin uptake binding protein ceuE
[11], the outer membrane phospholipase A pldA [12], aswell as the lipooligosaccharide sialyltransferases cstII and
cstIII [13,14].
Results
The frequency of all eight new determined genetic mar-
kers in all tested 266 isolates and in each subgroup is listed
in Table 1. Additionally the ratio of human isolates as par-
ameter for the clinical relevance of the particular isolate
group is listed there. A pictorial representation of the mar-
ker gene distribution among the various subgroups as well
as their isolate origin is shown in Figure 1.
The flagellin O-glycosylation locus cj1321-cj1326 as
marker for livestock-associated strains could be detected
in the majority of the isolate groups: 1A, 1B*, 1B**, 3A
and 4, assuming their livestock association. In contrast
to that, especially the groups 2A+B as well as 1B***, 3B
and 5 were negative for this marker gene.
A comparable distribution pattern could be demon-
strated for the fucP gene. The isolate groups 1A, 1B*,
1B**, 3A* and 6, are positive for this marker gene,
whereas the fucP genes was nearly absent in the groups
1B***, 2A+B, 3A** + B and 4.
Feodoroff and coworkers identified a subpopulation
in which they were not able to detect ceuE using ceuE-
primers derived from the NCTC 11168 genome sequence
[7]. The same phenomenon was described by them for
pldA using NCTC 11168 genome based primers, but here
the differences were not significant [7]. Using additional
forward primers based on the gnome sequence of the 81–
176 strain (see Table 2), we could detect ceuE and pldA in
the whole test population. Using exclusively the NCTC
11168 genome based primers a significant lowered ceuE-
detection rate was only observerd for group 2 isolates
(24.0%, p < 0.002). There were no significant differences in
the pldA detection using additional 81–176 genome-based
primes in our study population.
Furthermore, we included the genes cj0178, an outer
membrane siderophore receptor, and cj0755, an iron up-
take protein (ferric receptor), in the panel of marker
genes. The gene products of cj0178 and cj0755 are like
enterochelin, CeuE, involved in the microbial iron up-
take. Thus, it was, because of their functional association
to CeuE, suggestible that they may be associated with
bloody diarrhea like ceuE [7] as well. Both genes could
be detected, mostly associated with each other, in more
than 76% of all isolates. In the groups 2 (A+B) and 4
they are nearly completely absent, whereas about 100%
of the remaining groups are positive for both genes.
Additionally, we looked for the presence of cstII and
cstIII in order to distinguish isolates with sialylated LOS
from isolates with non-sialylated LOS. There are already
more detailed studies associating MLST CC with certain
LCC [3,15,16] allowing us to associate a particular iso-
late group with specific LCC only on the basis of the
Table 1 Distribution and association of genetic markers, LLC and MLST-CC within the determined subgroups
(sub-) group No. of isolates with marker gene/total no. (%) human origin
cj1321-1326 fucP cj0178 cj0755 ceuE11168
1 pldA11168
2 cstII cstIII LLC3
1a 38/38#(100) 38/38#(100) 38/38#(100) 38/38#(100) 38/38#(100) 38/38#(100) 13/38°(34.2) 33/38#(86.4) C/A 16/38(42.1)
1b* 43/44#(97.7) 44/44#(100) 44/44#(100) 44/44#(100) 42/44°(95.5) 41/44(93.2) 16/44°(36.4) 37/44#(84.1) C/A/B 19/44(43.2)
1b** 38/38#(100) 36/38#(94.7) 37/38#(97.4) 38/38#(100) 35/38(92.1) 37/38°(97.4) 37/38#(97.4) 2/38#(5.3) B2 19/38(50.0)
1b*** 7/15(46.7) 5/15°(33.3) 15/15#(100) 15/15#(100) 14/15#(93.3) 15/15#(100) 6/1z(40.0) 0/15#(0.0) B, D 9/15(60.0)
2a 2/17#(11.8) 0/17#(0.0) 0/17#(0.0) 3/17#(0.0) 12/17(70.6) 14/17(82.4) 16/17#(94.1) 1/17#(5.9) A1/B 8/17(47.1)
2b 3/34#(8.8) 1/34#(2.9) 1/34#(2.9) 1/34#(2.9) 26/34°(76.5) 29/34(85.3) 5/34#(14.7) 0/34#(0.0) D/E/H/U 22/34°(64.7)
3a* 15/22(68.2) 18/22°(81.8) 22/22#(100) 22/22#(100) 18/22(81.8) 18/22(81.8) 18/22#(81.8) 1/22#(4.5) - 15/22°(68.2)
3a** 16/19°(84.2) 2/19#(10.5) 19/19#(100) 19/19#(100) 18/19#(94.7) 11/19(57.9) 12/19(63.2) 7/19(36.8) E 4/19°(21.1)
3b 2/11°(18.2) 0/11#(0.0) 11/11#(100) 11/11#(100) 10/11(90.9) 8/11(72.7) 10/11(90.9) 1/11(9.1) - 3/11(27.3)
4 3/8(37.5) 0/8#(0.0) 1/8#(12.5) 0/8#(0.0) 7/8(87.5) 6/8(75.0) 5/8(62.5) 0/8#(0.0) - 2/8(25.0)
5 0/4#(0.0) 1/4(25.0) 4/4#(100) 4/4#(100) 4/4#(100) 4/4#(100) 2/4(50.0) 0/4#(0.0) - 1/4(25.0)
6 3/9(33.3) 9/9#(100) 9/9#(100) 9/9#(100) 8/9(88.8) 8/9(88.8) 2/9°(22.2) 0/9#(0.0) A/D 7/9(77.8)
all 170/266(63.9) 154/266(57.9) 204/266(76.7) 208/266(78.2) 232/266(87.2) 229/266(86.1) 142/266(53.4) 82/266(30.8) all 128/266(48.1)
Marker genes cjj1321-cj1326: O-linked flagellin glycosylation locus; fucP: L-fucose permease gene (cj0486); cj0178: outer membrane siderophore receptor; cj0755: iron uptake protein (ferric receptor cfrA); ceuE:
enterochelin uptake binding protein; pldA: outer membrane phospholipase A; cstII: LOS sialyltransferase II; cstIII: LOS sialyltransferase III; LLC: lipooligosaccharid (LOS) locus class; MLST-CC: Multilocus sequence typing
clonal complex; footnotes: 1negative corresponds to only detectable using the forward primer based on the 81-176 genome sequence: 5’-GAT-AGA-GTC-GCA-GGC-GTT-CC-3’+2negative corresponds to only detectable
using the forward primer based on the 81-176 genome sequence: 5’-AAA-CTT-ATG-CGT-TTT-T-3’ 3LLC according to Habib et al. 2009 [3], Hotter et al. 2010 [15], Revez et al. 2011 [16]; p<0.05/# p<0.001 significance level
in comparison to the remaining isolates belonging not to the corresponding group, additionally the values in subgroups with above average numbers of positive isolates are given in bold numbers; in the case of ceuE


















Figure 1 (See legend on next page.)
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Figure 1 MLST-sequence based UPGMA-tree and the arrangement of the six different marker genes within the six defined groups
(twelve subgroups). On the left side the MLST-sequence based UPGMA-tree of 266 C. jejuni isolates is depicted. The numbers shown on the
branches of the tree indicate the linkage distances. The right side of the table lists all isolates in the order of the UPGMA-tree depicting the
source of the isolate, the presence or absence of the six marker genes and their belonging to one of the groups listed in Table 1. Source: Human
isolates are marked blue, chicken isolates yellow, bovine isolates red, and turkey isolates green. Marker genes: Presence of a genetic marker is
marked with a light red shade, absence with a light green shade. The marker genes from left to right are: cjj1321-6: O-linked flagellin
glycosylation locus; fucP: L-fucose permease gene (cj0486); cj0178: outer membrane siderophore receptor; cj0755: iron uptake protein (ferric
receptor cfrA); ceuE: enterochelin uptake binding protein; pldA: outer membrane phospholipase A; cstII: LOS sialyltransferase II; cstIII: LOS
sialyltransferase III; The last column gives the group according to Table 1: light grey (1A), light yellow (1B*) intense yellow (1B**), dark yellow (1B***)
cyan blue (2A), bondi blue (2B), carrot-orange (3A*), orange-red (3A**); rust-red (3B), turquoise [4], red [5], steel-blue [6] and white (singeltons).
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presence of cstII and cstIII (see Table 1 and Figure 1).
Group 1A and 1B* were generally tested positive for
cstIII. The subgroup named 1B**, which is comprised of
CC 48 and CC 206 isolates, is only cstII but not cstIII
positive. Isolates from the subgroup 1B*** (CC 49 and
CC 446) are partially positive, partially negative for cstII
but generally cstIII-negative. All in all, 23 isolates are
positive for cstII and cstIII. Most of these double-positive
isolates belong to group 1 (87.0%) and CC 21 (65.2%).
The isolates of group 2A are in the majority cstII-posi-
tive, in contrast to group 2B isolates that are negative
for both, cstII and cstIII, which means that these isolates
bear a non-sialylated LOS. Most of the group 3 isolates
are positive for cstII but not cstIII, besides a minority of
CC 353 isolates that are cstIII-positive. The majority of
isolates in the groups 4, 5, and 6 are cstII- and cstIII-
negative (non-sialylated LOS).
Finally the ratio of human isolates in comparison to all
animal isolates was significantly (p = 0.04355) increased
in the ggt-positive subgroup 2B, whereas the difference
for the whole group 2 (A+B) was increased but not sig-
nificant. An increased ratio of human isolates could
be also detected for the fucP-negative subpopulation
(p(1B*** + 2) = 0.04790) as well as the ceuE-negative (re-
ferring to a PCR using NCTC 11168-based primers) sub-
population (p(2 + 3A*) = 0.00825). However, we could
not detect any significant association between a particu-
lar animal host species and the presence of the eight
tested genetic markers (results not shown). With the ex-
ception of group 1B** with a significant (p = 0.01374)
lower hospitalization rate and group 3A* with a signifi-
cant (p = 0.00020) lower rate of bloody diarrhea no sig-
nificant differences in the clinical parameters could be
detected within this study population.
Discussion
Looking at all detected genetic markers we could describe
two major types of marker gene combinations represented
by group 1A and group 2B. All other groups depict a grad-
ual transition of marker gene combinations between these
two groups. Thus the main focus on attention should beon these two groups. Group 1A is characterized by the
presence of cj1365c, cj1585c, dimeric tlp7 [2], cj1321-
cj1326, fucP, cj0178, cfrA/cj755, and ceuE11168 as well as
the absence of ansB, dmsA, ggt and cstII. In contrast to
that, group 2B is an inverted mirror image of this constel-
lation: positive for ansB, dmsA, ggt but negative for
cj1365c, cj1585c, dimeric tlp7 [2], cj1321- cj1326, fucP,
cj0178, cfrA/cj755, ceuE11168 as well as cstII/III.
Champion and coworkers identified the flagellin O-
glycosylation locus cj1321-cj1326 as marker present in
livestock-associated strains, whereas 55.7% of clinical iso-
lates were shown by them to be negative for this gene
cluster [6]. According to their data, cj1321-cj1326-negative
strains originate mostly from asymptomatic carriers and
the environment [6]. Due to our data, 63.9% of the tested
C. jejuni isolates show livestock association based on the
presence of cj1321-cj1326. But in contrast to their findings
the non-livestock-associated group 2B is significantly
more often associated with human origin and thus, bears
obviously higher pathogenic potential for humans than
the livestock-marker positive strains.
The fucP gene was shown to be present only in isolates
negative for ggt [8], which is in accordance with our find-
ings. The ggt-positive group 2 is almost completely free of
fucP-positive isolates. Interestingly, group 6 isolates, posi-
tive for the ggt-associated marker genes ansB and dmsA
but not for ggt, are mostly able to utilize L-fucose. The
fucP distribution pattern is similar to that of the livestock-
association marker genes cj1321-cj1326 and the serine
protease Cj1365 [2]. Thus, fucP should be considered as a
further marker for livestock association. It can be sug-
gested that the fucose permease is a crucial prerequisite
for dwelling in the mucosa layer, while it enables the bac-
terial cell to metabolize mucosal L-fucose.
The ability to acquire iron is an essential prerequisite for
bacterial replication and thus an important virulence fac-
tor especially in iron restricted environments [17,18].
While C. jejuni has no own siderophores [10] it makes use
of exogenous siderophores produced by accompanying
bacterial species [19]. At all five different iron uptake sys-
tems have been detected in the genome of C. jejuni NCTC
11168 [10], but the genome sequence of strain 81–176
Table 2 Primer
Gene Primer name Sequence 5’-3’ Annealing temp Reference
cj0178 cj0178-F01 TGTAGGCGGGGGTGGCAAGA 54.0°C this study
cj0178-R01 ACGACCGCGAGCAGAATTGC
cj0755/cfrA cj0755/cfrA-F01 ATGGCCGCGAAGTCGTAGGG 54.0°C this study
cj0755/cfrA-R01 AGCGATCTATTTGCCACTCGCCT
cj1321 CjNCTC11168-1321_f AAAATGTCATCATCATAGGAGCG 60.0°C [6]
CjNCTC11168-1321_r TCTAAGTTTACGCAAGGCAACA
cj1322 CjNCTC11168-1322_f GACTTTGGTTTAATGGGTAAGCA 59.6°C [6]
CjNCTC11168-1322_r TTCCGGCGTTAAAATTAGAAAA
cj1323 CjNCTC11168-1323_f AGAACGATTTACCCCATTGAAA 59.7°C [6]
CjNCTC11168-1323_r ATTTGCTAAAGCTCCTCGATTG
cj1324 CjNCTC11168-1324_f TGCCGTAAGTGGAGGTAAAGAT 60.0°C [6]
CjNCTC11168-1324_r TCTGCACACATTGTTCTATCCC
cj1325 CjNCTC11168-1325_f ACGGATTACTTTTTCCAGATGGT 60.0°C [6]
CjNCTC11168-1325_r TTTGCTTTGAAAATACGCTGAA
cj1326 CjNCTC11168-1326_f TACATTTCATCGATAAAGCCGA 59.7°C [6]
CjNCTC11168-1326_r AAATATAATGGTGTGCCGATCC




ceuE ceuE-81176F01 GATAGAGTCGCAGGCGTTCC 60°C this study
ceuE405F GATAAAGTCGTTGGCGTTCC [7]
ceuE405R GCGAGATTGGAGGACCAAAGG
pldA pldA-81178F01 AAACTTATGCGTTTTT 45°C this study
pldA-84fwd AAGCTTATGCGTTTTT [7]
pld-981rev TATAAGGCTTTCTCCA
cstII orf7ab ACTACACTTTAAAACATTTAATCC AAAATCA 56°C [14]
orf7ab CCATAAGCCTCACTAGAAGGTATGAGTATA
cstIII orf7c TTGAAGATAGATATTTTGTGGGTAAA 56°C [14]
orf7c CTTTAAGTAGTGTTTTATGTCACTTGG
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Cju15, a protein of unknown function, replaces the gene
cfrA/cj0755, which encodes a ferric uptake receptor [9].
A second iron uptake transport system encoded by the
genes cj0173c-cj0182 is missing critical components e.g.
cj0178 and tonB3 [9], and in the gene cluster encoding
the enterochelin uptake system cju30 is inserted be-
tween cj1355 and cj1356c [9]. Additionally the entero-
chelin uptake system (CeuBCDE; Cj1352 to Cj1355) is
ubiquitous within the C. jejuni population, but it shows
sequence variability detectable by PCR using different
primers. A C. jejuni subpopulation, associated with a
higher rate of bloody diarrhea requiring hospitalization,
was identified by Feodoroff and coworkers [7]. This sub-
population was positive for ggt, but ceuE was not detect-
able using ceuE-primers derived from the NCTC 11168genome sequence. This subpopulation corresponds to
group 2 in our scheme. In a significant number of group
2 isolates it was only possible to detect the ubiquitous
gene for ceuE using primers derived from the genome
sequence of C. jejuni strain 81–176 (for pldA we
detected no significant differences). In this group of iso-
lates the iron uptake system components cj0178 and
cfrA/cj755 are absent in nearly 100% of the isolates.
Thus, the two groups identified by Feodoroff et al. asso-
ciated with bloody stools/GGT-production and an
increased hospitalization rate/ceuE11168-presence overlap
to a larger part that corresponds to group 2B. Besides
ggt and ceuE11168, cj0178 and cfrA/cj755 should be con-
sidered as marker genes correlating with clinical data.
Parker et al. defined, according to the organization of
the LOS locus, various LOS locus classes (LLC). The
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acid synthase (neuBCA) and two class-specific sialyl-
transferases: cstII in LLC A, B, M, R and cstIII in LLC C
[19,20]. It was demonstrated that the LOS plays a role
for epithelial cell invasion [4] and is associated with the
clinical course of gastro-enteritis [5]. In this study, we
detected just the key-enzymes for LOS sialylization cstII
and cstIII. Besides the isolates of the groups 2B and 6,
the test population was either cstII or cstIII positive.
Group 1A and 1B* isolates were predominantly positive
for cstIII. This corresponds to the results of Habib et al.
that CC 21 belongs to either LCC C or LCC A [3]. The
subgroup 1B**, consisting of CC 48 and 206 isolates, is
only cstII but not cstIII positive, corresponding mostly to
LLC B [3,15]. The isolates of the subgroup 1B*** (CC 49
and CC 446) were demonstrated to be partially positive,
partially negative for cstII but generally cstIII-negative.
This corresponds to LLC B and D due to few isolates
described by Habib et al. [3]. The majority of group 2A
isolates was tested positive for cstII, corresponding to
LCC A1 and B [3,16] in contrast to group 2B isolates
that were tested negative for both cstII and cstIII and
belong to LLC D and E(H) [3]. Positive tested for cstII
but not cstIII was the majority of isolates in group 3.
An exclusion were the isolates of CC 353 that are
cstIII-positive (corresponding to LCC C). The negative
test result for cstII- and cstIII of the majority of isolates
in the groups 4, 5, and 6 implies that they belong to
LLCs with non-sialylated LOS. Hotter et al. associated
LCC D and E, corresponding to group 2B in our study,
with an increased hospitalization rate [5], that is in ac-
cordance with the results obtained by Feodoroff and
coworkers for the ggt-positive and ceuE11168-negative
group [6] as well as with our prevalence rates for iso-
lates of human origin. In contrast to our data and the
data of Feodoroff et al. [7] Hotter and coworkers asso-
ciated LCC B and C with a higher frequency of bloody
stools [5]. This group of isolates corresponds for the
most part to the group 1 but also 2A.
Conclusions
In general, the arrangement of the eight additional mar-
ker genes and the ratio of isolates of human origin sub-
stantiates and complements our prior definition of the
subgroups.
One outstanding population formed by the groups
1A+B, which is able to utilize L-fucose, seems to be
livestock-adapted due to the presence of cj1321-cj1326,
cj1365c and cstII and/or cstIII, and has all of the five
identified putative iron uptake systems of C. jejuni.
These strains do not exhibit the genes for an extended
amino acid metabolism. Due to their livestock adapta-
tion these isolates are less prevalent in humans and sec-
ondarily associated with less severe campylobacteriosis.Contrary to that, group 2 isolates possess an extended
amino acid metabolism (positive for ansB, dmsA,
as well ggt) and are not able to metabolize L-fucose
(fucP-negative). Group 2 isolates possess only three of
five iron uptake systems. This group splits into the two
subgroups 2A and 2B. The subgroup 2B is additionally
negative for the livestock markers cj1365c, cj1321-
cj1326, as well as cstII/III. In contrast to that, subgroup
2A is positive for cj1365c and cstII, but cj1321- cj1326 is
likewise not present. Additionally, subgroup 2A is char-
acterized by the presence of the flagellum-secreted non-
flagellar protein A1 encoded by fspA1 [20]. The
remaining subgroups demonstrate a somewhat inter-
mediate marker gene profile compared to 1A and 2B. In
this respect, group 6 seems noteworthy, as the corre-
sponding isolates are positive for ansB and dmsA, typical
for group 2 as well as fucP, cj0178, cj0755 and cj1365c
typical for group 1 but not ggt or cj1321- cj1326. Fur-
thermore, only half of group 6 isolates posses a sialylated
LOS.
The high virulent isolate subpopulations identified by
Mortensen, who associated LCC D and E with a higher
hospitalization rate [5] and these of Feodoroff, who asso-
ciated ggt and a ceuE gene, that is not detectable with
primers based on the NCTC 11168 sequence, with se-
vere campylobacteriosis and bloody diarrhea [7], seem to
overlap at least partially in group 2, with the highest
pathogenic potential i.e. the highest virulence for
humans. Surprisingly, the asymptomatic colonizers iden-
tified by Champion et al. [6] and isolates bearing a non-
sialylated LOS seem to predominate this high virulent
isolate group.
Finally, it should be questioned especially for cstII/III,
if there is a causal relationship between a particular gen-
etic marker and clinical parameters, while particular
genetic markers are associated with each other and the
causal relationship to clinical parameters could be due
to a causal relation of an associated genetic marker.
Methods
C. jejuni isolates
A total of 266 C. jejuni isolates, 128 of human, 66 of
chicken, 45 of bovine, and 27 of turkey origin, with already
determined MLS-type and characterized for six genetic
markers were selected from our collection [2]. That means
about half of the isolates were of human (128) and half of
animal (138) origin, what should help to make statements
about the clinical relevance of a particular isolate group
due to the proportion of isolates originating from human
stool samples. The avian and bovine isolates were obtained
from the German Campylobacter reference center at the
Bundesinstitut für Risikobewertung (Federal Institute for
Risk Assessment) in Berlin, Germany. The human isolates
originate from stool samples of hospitalized patients of the
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well as outpatients of several doctor’s offices in the city
of Göttingen (60%). For these strains the parameters
watery diarrhea (85%) vs. bloody diarrhea (15%) are
known. Additionally 42 well-characterized isolates of the
CampyNet research network strain collection were
included as references. All isolates of this study were
PCR-positive for ciaB and the cdtB.
The C. jejuni isolates were cultured on Columbia agar
base (Merck) supplemented with 5% sheep blood (BA)
and incubated at 42°C under microaerophilic conditions
(5% O2, 10% CO2, 85% N2) for 24 hours prior to DNA
extraction.
DNA extraction and marker gene detection
Genomic DNA of C. jejuni was isolated using the
QIAamp DNA Mini Kit (Qiagen) according to the man-
ufacturer’s instructions. For detection of the different
genetic markers the primers listed in Table 2 were used.
Phylogenetic analysis
For construction of a UPGMA-dendrogram (unweighted-
pair group method using average linkages) the MEGA4
software was used [21], and the C. jejuni MLST website
(http://pubmlst.org/campylobacter/) developed by Keith
Jolley and Man-Suen Chan, sited at the University of
Oxford was consulted for assignation of sequence types
and clonal complexes [22].
Statistical analyses
Statistical analysis was performed using the Statistica
software. The χ²-test was used to test for significant dif-
ferences/similarities in the frequencies of the various
genetic markers within the defined groups. The obtained
p-values are indicated in Table 1.
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